These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 14314907)
1. USE AND ABUSE OF DRUGS. DUNLOP D Br Med J; 1965 Aug; 2(5459):437-41. PubMed ID: 14314907 [No Abstract] [Full Text] [Related]
2. AN INTERNATIONAL DRUG SAFEGUARD PLAN. FINNEY DJ J Chronic Dis; 1964 Jul; 17():565-81. PubMed ID: 14179659 [No Abstract] [Full Text] [Related]
3. THE PHYSICIAN AS FINAL ARBITER? PAGE I Appl Ther; 1964 Apr; 6():293-5. PubMed ID: 14152073 [No Abstract] [Full Text] [Related]
4. THE USE OF EXPERIMENTAL DRUGS AND TECHNICS. WASMUTH CE Anesth Analg; 1964; 43():187-9. PubMed ID: 14164940 [No Abstract] [Full Text] [Related]
5. PROBLEMS IN DRUG DEVELOPMENT AS THEY RELATE TO THE CLINICAL INVESTIGATOR. PFEIFFER CC J New Drugs; 1964; 4(6):299-305. PubMed ID: 14247770 [No Abstract] [Full Text] [Related]
6. Future shock: drug therapy and the U.S. pharmaceutical industry. Ellenhorn MJ J Clin Pharmacol; 1975; 15(5-6):385-400. PubMed ID: 1133216 [No Abstract] [Full Text] [Related]
7. PROBLEMS IN DRUG DEVELOPMENT AS THEY RELATE TO THE PHARMACEUTICAL INDUSTRY. WINTER IC J New Drugs; 1964; 4(6):306-11. PubMed ID: 14247771 [No Abstract] [Full Text] [Related]
8. THE PRICE OF THERAPEUTIC PROGRESS. BINNS TB Scott Med J; 1965 Mar; 10():130-4. PubMed ID: 14262967 [No Abstract] [Full Text] [Related]
9. [FORENSIC SIGNIFICANCE OF PRESCRIPTION-FREE SEDATIVES AND HYPNOTICS]. WAGNER HJ Acta Med Leg Soc (Liege); 1964; 17():11-20. PubMed ID: 14250402 [No Abstract] [Full Text] [Related]
10. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA. WESTON JK; WESTON K Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685 [No Abstract] [Full Text] [Related]
11. NEW DRUG SURVEILLANCE IN 1964. ELLENHORN MJ Am J Pharm Sci Support Public Health; 1964; 136():114-27. PubMed ID: 14167236 [No Abstract] [Full Text] [Related]
12. AIDS drugs & the pharmaceutical industry: a need for reform. Griffin MT Am J Law Med; 1991; 17(4):363-410. PubMed ID: 1812767 [TBL] [Abstract][Full Text] [Related]
13. NEW DRUG SURVEILLANCE IN 1964. ELLENHORN MJ J New Drugs; 1964; 4(3):166-75. PubMed ID: 14185008 [No Abstract] [Full Text] [Related]
14. [RESPONSIBILITY OF THE PHYSICIAN IN THE PRESCRIPTION OF DRUGS, ETC. IN THE SYMPTOMS OF TOXICOMANIA]. VARENNE G Belg Tijdschr Geneesk; 1963 Aug; 19():830-40. PubMed ID: 14045294 [No Abstract] [Full Text] [Related]
15. PROPORTIONATE COSTS OF DRUG TESTING IN ANIMALS. BONFIELD CT Lab Anim Care; 1964 Oct; 14():404-8. PubMed ID: 14212342 [No Abstract] [Full Text] [Related]
16. [ASPECTS OF THE TOXICITY OF DRUGS IN THE PRACTICE OF THE PHARMACEUTICAL INDUSTRY]. REGGIANI G Clin Ter; 1964 Jan; 28():3-28. PubMed ID: 14126098 [No Abstract] [Full Text] [Related]
17. NEW DRUG REGULATIONS--A YEAR'S PERSPECTIVE. STETLER CJ New Physician; 1964 Mar; 13():75-7. PubMed ID: 14126411 [No Abstract] [Full Text] [Related]
18. [ANIMAL AND HUMAN EXPERIMENTATION WITH NEW DRUGS]. MARCONI M; DOMINICI A Clin Ter; 1964 Jun; 29():562-81. PubMed ID: 14184056 [No Abstract] [Full Text] [Related]
19. DRUGS AND THE DOCTOR. MACGREGOR AG Appl Ther; 1963 Sep; 5():753-60. PubMed ID: 14067520 [No Abstract] [Full Text] [Related]
20. BRAND NAMES OR PROPER NAMES. DANIEL EE Can Med Assoc J; 1964 Nov; 91(21):1129-30. PubMed ID: 14229766 [No Abstract] [Full Text] [Related] [Next] [New Search]